POET seals $50M Lumilens AI optical engine JV deal
Key Questions
What is the POET-Lumilens joint venture deal?
POET entered a $50M PO/JV agreement with Lumilens to develop an AI E-O interposer, with potential value up to $500M over five years. The deal supports POET's focus on AI optical engines and aligns with its production ramp timeline.
How did POET's stock perform following the deal announcement?
Shares rose 43% overnight and 88% weekly before a 22% decline to $15.97 after a $400M raise. The stock later traded around $13.93 and declined further to €7.30 amid dilution concerns.
What production and operational milestones has POET outlined?
POET targets 1M units per month by end of 2027 with $50M capex, supported by over 10 customer engagements expected to yield $100M+ annual revenue. The company is hiring over 115 engineers and plans 30k modules from its Malaysia factory in 2026, with wafer orders from SilTerra rising 823%.
$50M PO/JV with Lumilens for AI E-O interposer ($500M potl/5yrs); shares jumped 43% overnight then +88% weekly before 22% drop to $15.97 post-$400M raise. Valuation PS 22.92. AGM update confirms production ramp on track for H2 2026, targeting 1M units/month by end of 2027 with $50M capex and $830M raised. Over 10 customer engagements expected to generate $100M+ annual revenue. Hiring sprint (115+ engineers) and Malaysia factory targeting 30k modules in 2026 reinforce execution push. Wafer orders from SilTerra jumped 823% to 600/month, a strong scaling signal. Price action at $13.93 after raise, but recent articles show continued decline to €7.30 (58% below peak) on dilution fears. New: Four institutions have crossed 5% in POET in under 60 days, including MMCAP (11% from $400M raise), Jane Street and Citadel (both market makers), reinforcing institutional interest with nuance between fundamental buyers and liquidity providers.